Login
$PALX
$14.34 +$0.33 (2.36%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Assets
Cash
Current assets:
Cash
Cash and cash equivalents
Prepaids and other current assets
Total current assets
Property and equipment, net
Right of use asset, net
Deferred financing costs
Other assets
Total assets
Liabilities and stockholders’ equity
Current liabilities:
Related party payables
Accounts payable
Accrued expense and other liabilities
Related party note payables
Related Party
Total related party note payables
Accrued interest - related party note payables
Shareholder note
Related Party
Total shareholder note
Accounts payable and accrued expenses
Accrued interest - note payable - Lucius Partners Opportunity Fund
Note payable - stockholder
Note payable - Lucius Partners Opportunity Fund
Operating lease liability, current
Total current liabilities
SAFE notes
Operating lease liability, noncurrent
Total liabilities
Stockholders’ equity:
Common stock, $0.0001 par value; 300,000,000 shares authorized; 23,164,539 and 18,770,686 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support